Each named dose 2.5, 5, 7.5, 10, 12.5, 15 mg corresponds to a documented step
[1] Multiple Endocrine Neoplasia syndrome type 2 (MEN2) a genetic condition that predisposes to MTC
Why Choose MinuteMed Walk-In Clinic in Lafayette, LA Experienced Providers: Our team specializes in GLP-1 therapy for weight management and diabetes care
For type 2 diabetes management , licensed GLP-1 medications include: Exenatide (Byetta, Bydureon) available as twice-daily or once-weekly formulations Liraglutide (Victoza) administered once daily Dulaglutide (Trulicity) given once weekly Semaglutide (Ozempic) administered once weekly as an injection Semaglutide (Rybelsus) taken orally once daily (for type 2 diabetes only, not licensed for weight management) For weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, two medications hold specific licences: Liraglutide 3.0 mg (Saxenda) once-daily subcutaneous injection Semaglutide 2.4 mg (Wegovy) once-weekly subcutaneous injection Access to these medications through the NHS is governed by NICE guidance
What are the side effects of compounded GLP-1 therapy